Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?

In dialysis patients the humoral response to anti-SARS-CoV-2 vaccines is attenuated and rapidly declines over time. However, data on the persistence of the immune response in peritoneal dialysis (PD) patients are scarce, particularly after a third (booster) dose with mRNA-1273 vaccine. In this prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Beilhack, Georg, Monteforte, Rossella, Frommlet, Florian, Reindl-Schwaighofer, Roman, Strassl, Robert, Vychytil, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263093/
https://www.ncbi.nlm.nih.gov/pubmed/35814775
http://dx.doi.org/10.3389/fmed.2022.905798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263093/
https://www.ncbi.nlm.nih.gov/pubmed/35814775
http://dx.doi.org/10.3389/fmed.2022.905798

Ejemplares similares